Skip to main navigation
Skip to search
Skip to main content
Penn State Home
Help & FAQ
Link opens in a new tab
Search content at Penn State
Home
Researchers
Research output
Research units
Equipment
Grants & Projects
Prizes
Activities
Vancomycin and nephrotoxicity: Just another myth?
Stephen W. Davies
, Christopher A. Guidry
, Robin T. Petroze
, Tjasa Hranjec
, Robert G. Sawyer
Department of Surgery
Research output
:
Contribution to journal
›
Article
›
peer-review
26
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vancomycin and nephrotoxicity: Just another myth?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nephrotoxicity
100%
Vancomycin
100%
Linezolid
85%
Relative Risk
71%
Confidence Interval
71%
Creatinine Level
57%
Antibiotic Therapy
42%
Hemodialysis
42%
Between-group
28%
Gram-positive Infections
28%
Patient Demographics
14%
Creatinine
14%
Multivariable
14%
Multivariable Logistic Regression
14%
Drug Choice
14%
Retrospective Cohort Study
14%
Intensive Care Unit
14%
Critically Ill Patients
14%
Surgical Patients
14%
Health Assessment
14%
Increased Incidence
14%
Treatment Course
14%
Gram-positive
14%
Chronic Conditions
14%
Hospital Discharge
14%
Acute Physiology
14%
Methicillin-resistant Staphylococcus Aureus Infection
14%
Antibiotic Protocol
14%
Nursing and Health Professions
Vancomycin
100%
Nephrotoxicity
100%
Confidence Interval
62%
Creatinine
62%
Antibiotic Therapy
37%
Hemodialysis
37%
Logistic Regression Analysis
12%
Cohort Analysis
12%
Infection
12%
Intensive Care Unit
12%
Hospital Discharge
12%
APACHE
12%
Methicillin Resistant Staphylococcus Aureus Infection
12%
Pharmacology, Toxicology and Pharmaceutical Science
Nephrotoxicity
100%
Vancomycin
100%
Linezolid
75%
Creatinine
62%
Antibiotic Therapy
37%
Hemodialysis
37%
Gram Positive Infection
25%
Cohort Study
12%
Infection
12%
Trough Level
12%
Methicillin Resistant Staphylococcus Aureus Infection
12%
Biochemistry, Genetics and Molecular Biology
Vancomycin
100%
Linezolid
75%
Creatinine
62%
Hemodialysis
37%
Cohort Study
12%
Methicillin Resistant Staphylococcus Aureus
12%
Immunology and Microbiology
Hemodialysis
100%
Methicillin-Resistant Staphylococcus Aureus
33%